Diabetic ophthalmopathy is clinically called diabetic retinopathy.

(DR) is a common retinal vascular disease, the most common chronic complication of diabetes, and the main factor leading to blindness in adults.

The development of disease and diabetes

Time of onset and blood sugar

Control the situation.

Diffuse or focal vascular leakage (hard exudation, punctate bleeding, etc.) is not easy to be found in the early stage of diabetes. ) Lesions involving macula can be displayed in macula area. Progressive vascular diseases can occur, including microangiomas, retinal hemorrhage, vascular tortuosity and vascular malformation, which eventually lead to abnormal capillary formation; Retinal capillary occlusion can lead to different degrees of vision loss.

Type 2 diabetes mellitus

The patient needs the first comprehensive eye examination after the diagnosis.

1 type diabetes mellitus

Patients should have a comprehensive ophthalmological examination within 5 years after diagnosis.

No diabetic retinopathy

Patients with diabetic retinopathy should have eye reexamination at least once every 1~2 years, and the frequency of examination should be increased according to the severity of the lesion.

The main manifestation of diabetic ophthalmopathy is decreased vision. There may be no typical symptoms in the early stage. With the development of the disease, vision will gradually decline, which can lead to blindness in severe cases.

At present, the treatment of diabetic eye disease mainly needs to control high-risk factors, such as blood sugar.

Management, blood pressure

Control and blood lipid

Adjustment; In addition, retinal photocoagulation and vitrectomy, anti-vascular endothelial growth factor therapy and glucocorticoid therapy can be considered for advanced lesions.